STRATA Skin Sciences, Inc. (SSKN)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenues, net | 7,663 | 6,812 | 8,797 | 8,435 |
| Cost of revenues | 3,357 | 3,165 | 3,490 | 3,498 |
| Gross profit | 4,306 | 3,647 | 5,307 | 4,937 |
| Selling and marketing | 3,533 | 2,993 | 3,048 | 3,014 |
| Engineering and product development | 86 | 96 | 243 | 199 |
| General and administrative | 2,911 | 2,573 | 3,669 | 2,210 |
| Total operating expenses | 6,530 | 5,662 | 6,960 | 5,423 |
| Loss from operations | -2,224 | -2,015 | -1,653 | -486 |
| Other income | - | - | - | 864 |
| Interest income | 226 | 69 | 68 | 54 |
| Interest expense | 491 | 486 | 537 | 531 |
| Total other (expense) income | -265 | -417 | -469 | 387 |
| Net loss | -2,489 | -2,432 | -2,122 | -99 |
| Net loss per share of common stock - basic (in dollars per share) | -0.6 | -0.58 | -0.53 | -0.03 |
| Net loss per share of common stock - diluted (in dollars per share) | -0.6 | -0.58 | -0.53 | -0.03 |
| Weighted average shares of common stock outstanding - basic (in shares) | 4,171,161 | 4,171,161 | 4,038,988 | 3,506,025 |
| Weighted average shares of common stock outstanding - diluted (in shares) | 4,171,161 | 4,171,161 | 4,038,988 | 3,506,025 |